California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...

US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...

Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...

Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...

US biopharma firm Viridian Therapeutics has entered into a royalty financing agreement with DRI Healthcare Acquisitions (DRI) and accelerated its timelines for the submission of the veligrotug BLA and ...

Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...

Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...

Danish allergy immunotherapy specialist ALK Abello has announced that EURneffy 2mg nasal adrenaline spray, the UK’s first ...

US biotech Exelixis has announced detailed results from STELLAR-303, a global Phase III pivotal trial evaluating ...

New data from the FLUNITY-HD study, published on October 17 in The Lancet, demonstrated that Sanofi's Efluelda known as Fluzone High-Dose in North America) significantly reduced the risk of ...

Swedish Orphan Biovitrum, the Nordic biotech company also known as Sobi, today announced positive third-quarter 2025 ...